Bal Pharma

{
  "main_header": {
    "sid": 555664,
    "name": "Bal Pharma",
    "stock_name": "Bal Pharma",
    "full_name": "Bal Pharma Ltd",
    "name_url": "stocks-analysis/bal-pharma",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "68.68",
    "chg": 1.76,
    "chgp": "2.63%",
    "dir": 1,
    "prev_price": "66.92",
    "mcapval": "111.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524824,
    "symbol": "BALPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE083D01012",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "10.1 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bal-pharma-555664-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Bal Pharma Ltd Stock Hits 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3816450",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BalPharmaLtd_priceRelatedfactors_3816450.png",
        "date": "2026-02-02 11:19:53",
        "description": "Bal Pharma Ltd’s shares declined sharply to a fresh 52-week low of Rs.64 on 2 Feb 2026, marking a significant downturn in the stock’s performance over the past year. The stock’s fall reflects ongoing pressures on the company’s financial metrics and relative underperformance within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Bal Pharma Ltd Stock Falls to 52-Week Low of Rs.65.01",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltd-stock-falls-to-52-week-low-of-rs6501-3811513",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/BalPharmaLtd_priceRelatedfactors_3811513.png",
        "date": "2026-01-30 12:06:05",
        "description": "Bal Pharma Ltd’s shares declined to a fresh 52-week low of Rs.65.01 on 30 Jan 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical company’s stock has underperformed both its sector and the broader market, reflecting persistent pressures on its financial and operational metrics."
      },
      {
        "title": "Bal Pharma Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-is-rated-strong-sell-3809344",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/BalPharmaLtd_mojoScore_3809344.png",
        "date": "2026-01-29 10:10:29",
        "description": "Bal Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 29 January 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Bal Pharma Ltd Falls to 52-Week Low of Rs.66 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltd-falls-to-52-week-low-of-rs66-amidst-continued-downtrend-3805640",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/BalPharmaLtd_priceRelatedfactors_3805640.png",
        "date": "2026-01-27 10:10:52",
        "description": "Bal Pharma Ltd’s shares touched a fresh 52-week low of Rs.66 today, marking a significant decline amid sustained downward momentum. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on the company’s financial performance and valuation metrics."
      },
      {
        "title": "Bal Pharma Ltd Stock Falls to 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltd-stock-falls-to-52-week-low-amidst-continued-downtrend-3801681",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/BalPharmaLtd_priceRelatedfactors_3801681.png",
        "date": "2026-01-23 11:30:38",
        "description": "Bal Pharma Ltd’s share price has declined to a fresh 52-week low of ₹67.15, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical company’s shares are currently trading just 1.25% above this low, reflecting sustained pressure amid subdued financial performance and valuation concerns."
      },
      {
        "title": "Why is Bal Pharma Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-bal-pharma-ltd-fallingrising-3797253",
        "imagepath": "",
        "date": "2026-01-21 01:04:49",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Despite opening the day with a 2% gain and touching an intraday high of ₹72.5, the stock ultimately succumbed to selling pressure, closing near its intraday low. Notably, the weighted average price indicates that a larger volume of shares traded closer to the day’s low, suggesting stronger selling interest as the session progressed. The stock is now trading just 1.29% above its 52-week low of ₹67.15, underscoring its vulnerability.</p>\n<p>Bal Pharma’s performance today also lagged behind its sector peers, with the Pharmaceuticals &amp; Drugs sector declining by 2.1%. The stock underperformed the sector by 1.36%, signalling relative weakness amid broader industry challenges. Furthermore, the stock has been trading below all key moving a..."
      },
      {
        "title": "Bal Pharma Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-is-rated-strong-sell-3783128",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/BalPharmaLtd_mojoScore_3783128.png",
        "date": "2026-01-06 10:10:26",
        "description": "Bal Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Bal Pharma Ltd Falls to 52-Week Low of Rs.67.15 Amidst Continued Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltd-falls-to-52-week-low-of-rs6715-amidst-continued-underperformance-3775264",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BalPharmaLtd_priceRelatedfactors_3775264.png",
        "date": "2025-12-30 16:01:18",
        "description": "Bal Pharma Ltd’s shares declined to a fresh 52-week low of Rs.67.15 on 30 Dec 2025, marking a significant milestone in the stock’s ongoing downward trajectory. This new low reflects a sustained period of underperformance relative to the broader market and sector benchmarks."
      },
      {
        "title": "Bal Pharma Ltd Stock Falls to 52-Week Low of Rs.67.15",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltd-stock-falls-to-52-week-low-of-rs6715-3773231",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BalPharmaLtd_priceRelatedfactors_3773231.png",
        "date": "2025-12-29 10:28:49",
        "description": "Bal Pharma Ltd’s shares declined to a fresh 52-week low of Rs.67.15 today, marking a significant milestone in the stock’s ongoing downward trajectory. This new low reflects persistent pressures on the company’s valuation amid subdued financial performance and sector-wide challenges."
      }
    ],
    "total": 120,
    "sid": "555664",
    "stock_news_url": "https://www.marketsmojo.com/news/bal-pharma-555664"
  },
  "announcements": [
    {
      "details": "Bal Pharma Limited has informed the Exchange regarding Disclosure of Related Party Transaction disclosure under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Bal Pharma Limited - Other General Purpose",
      "datetime": "28-Nov-2019"
    },
    {
      "details": "Bal Pharma Limited Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Bal Pharma Limited - Clarification - Financial Results",
      "datetime": "26-Nov-2019"
    },
    {
      "details": "Bal Pharma Limited has informed the Exchange regarding 'News Paper Publication's of Unaudited financial results for the quarter and half year ended 30/09/2019.'.",
      "source": "NSE",
      "caption": "Bal Pharma Limited - Updates",
      "datetime": "18-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bal Pharma Ltd has declared <strong>12%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Bal Pharma Ltd Stock Hits 52-Week Low Amidst Continued Downtrend

2026-02-02 11:19:53

Bal Pharma Ltd’s shares declined sharply to a fresh 52-week low of Rs.64 on 2 Feb 2026, marking a significant downturn in the stock’s performance over the past year. The stock’s fall reflects ongoing pressures on the company’s financial metrics and relative underperformance within the Pharmaceuticals & Biotechnology sector.

Read full news article

Bal Pharma Ltd Stock Falls to 52-Week Low of Rs.65.01

2026-01-30 12:06:05

Bal Pharma Ltd’s shares declined to a fresh 52-week low of Rs.65.01 on 30 Jan 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical company’s stock has underperformed both its sector and the broader market, reflecting persistent pressures on its financial and operational metrics.

Read full news article

Bal Pharma Ltd is Rated Strong Sell

2026-01-29 10:10:29

Bal Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 29 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Bal Pharma Ltd Falls to 52-Week Low of Rs.66 Amidst Continued Downtrend

2026-01-27 10:10:52

Bal Pharma Ltd’s shares touched a fresh 52-week low of Rs.66 today, marking a significant decline amid sustained downward momentum. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on the company’s financial performance and valuation metrics.

Read full news article

Bal Pharma Ltd Stock Falls to 52-Week Low Amidst Continued Downtrend

2026-01-23 11:30:38

Bal Pharma Ltd’s share price has declined to a fresh 52-week low of ₹67.15, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical company’s shares are currently trading just 1.25% above this low, reflecting sustained pressure amid subdued financial performance and valuation concerns.

Read full news article

Why is Bal Pharma Ltd falling/rising?

2026-01-21 01:04:49

Recent Price Movement and Market Context

Despite opening the day with a 2% gain and touching an intraday high of ₹72.5, the stock ultimately succumbed to selling pressure, closing near its intraday low. Notably, the weighted average price indicates that a larger volume of shares traded closer to the day’s low, suggesting stronger selling interest as the session progressed. The stock is now trading just 1.29% above its 52-week low of ₹67.15, underscoring its vulnerability.

Bal Pharma’s performance today also lagged behind its sector peers, with the Pharmaceuticals & Drugs sector declining by 2.1%. The stock underperformed the sector by 1.36%, signalling relative weakness amid broader industry challenges. Furthermore, the stock has been trading below all key moving a...

Read full news article

Bal Pharma Ltd is Rated Strong Sell

2026-01-06 10:10:26

Bal Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Bal Pharma Ltd Falls to 52-Week Low of Rs.67.15 Amidst Continued Underperformance

2025-12-30 16:01:18

Bal Pharma Ltd’s shares declined to a fresh 52-week low of Rs.67.15 on 30 Dec 2025, marking a significant milestone in the stock’s ongoing downward trajectory. This new low reflects a sustained period of underperformance relative to the broader market and sector benchmarks.

Read full news article

Bal Pharma Ltd Stock Falls to 52-Week Low of Rs.67.15

2025-12-29 10:28:49

Bal Pharma Ltd’s shares declined to a fresh 52-week low of Rs.67.15 today, marking a significant milestone in the stock’s ongoing downward trajectory. This new low reflects persistent pressures on the company’s valuation amid subdued financial performance and sector-wide challenges.

Read full news article

View All News